Short Interest in Integrated BioPharma, Inc. (OTCMKTS:INBP) Declines By 83.3%

Integrated BioPharma, Inc. (OTCMKTS:INBP) was the target of a large decrease in short interest in February. As of February 15th, there was short interest totalling 400 shares, a decrease of 83.3% from the January 31st total of 2,400 shares. Based on an average daily volume of 69,500 shares, the days-to-cover ratio is presently 0.0 days.

Integrated BioPharma Trading Down 8.9 %

Shares of OTCMKTS:INBP traded down $0.03 during trading on Thursday, reaching $0.28. The company had a trading volume of 300 shares, compared to its average volume of 19,668. The company has a fifty day moving average of $0.34 and a two-hundred day moving average of $0.29. The stock has a market capitalization of $8.50 million, a P/E ratio of 9.35 and a beta of 0.62. Integrated BioPharma has a 12 month low of $0.16 and a 12 month high of $0.42.

Integrated BioPharma Company Profile

Integrated BioPharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers.